Should Direct Thrombin Inhibitors be the Anticoagulant of Choice for Patients on Extracorporeal Membrane Oxygenation?: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ttenbergen (talk | contribs) mNo edit summary |
||
| Line 8: | Line 8: | ||
| GoogleScholarLink = | | GoogleScholarLink = | ||
| PubMedLink = | | PubMedLink = | ||
| DOILink = | | DOILink = https://doi.org/10.1016/j.cjca.2020.07.202 | ||
| wikilinks = | | wikilinks = | ||
| ThroughMCHP = no | | ThroughMCHP = no | ||
}} | }} | ||
Latest revision as of 11:12, 2021 May 6
| Publication | |
| Publication: | Should Direct Thrombin Inhibitors be the Anticoagulant of Choice for Patients on Extracorporeal Membrane Oxygenation? |
| Year: | 2020 |
| Authors: | H Muller Moran, R Eikelboom, R Adriano, R Manji |
| Publication Type: | Abstract |
| Journal: | Canadian Journal of Cardiology |
| DOI: | https://doi.org/10.1016/j.cjca.2020.07.202 |
| Program: | Critical Care |
| Through MCHP: | no |